Payments to Acquire Property, Plant, and Equipment of Sarepta Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Sarepta Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Sarepta Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $43,651,000, a 35% increase year-over-year.
  • Sarepta Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $101,972,000, a 26% decline from 2024.
  • Sarepta Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $136,956,000, a 80% increase from 2023.
  • Sarepta Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $76,106,000, a 147% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Sarepta Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $101,972,000 -$34,984,000 -26% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $136,956,000 +$60,850,000 +80% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 $76,106,000 +$45,282,000 +147% 01 Jan 2023 31 Dec 2023 10-K 02 Mar 2026 2025 FY
2022 $30,824,000 -$7,666,000 -20% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $38,490,000 -$43,712,000 -53% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $82,202,000 +$22,571,000 +38% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $59,631,000 -$1,526,000 -2.5% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $61,157,000 +$49,157,000 +410% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $12,000,000 +$6,659,000 +125% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $5,341,000 +$1,940,000 +57% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $3,401,000 -$22,043,000 -87% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $25,444,000 +$23,074,000 +974% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $2,370,000 +$2,262,000 +2094% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $108,000 -$1,070,000 -91% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
2011 $1,178,000 +$346,000 +42% 01 Jan 2011 31 Dec 2011 10-K 03 Mar 2014 2013 FY
2010 $832,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY

Sarepta Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $43,651,000 +$11,207,000 +35% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $32,444,000 +$22,959,000 +242% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $9,485,000 +$3,934,000 +71% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $5,551,000 -$15,598,000 -74% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2021 $21,149,000 +$12,029,000 +132% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $9,120,000 -$7,143,000 -44% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $16,263,000 +$4,097,000 +34% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $12,166,000 +$7,701,000 +172% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $4,465,000 +$3,297,000 +282% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $1,168,000 +$636,000 +120% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $532,000 -$4,794,000 -90% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $5,326,000 -$3,674,000 -41% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $9,000,000 $0 0% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $9,000,000 +$8,773,000 +3865% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $227,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.